KIM PETER S has filed 17 insider transactions across 1 company since March 2024.
Most recent transaction: a purchase of 25000 shares of Entrada Therapeutics, Inc. ($TRDA) on May 13, 2024.
Activity breakdown: 13 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 25000 | $14.68 | 92,412.0000 | 33,050,319 | 37.09% | 0.08% |
| May 14, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 25000 | $14.59 | 117,412.0000 | 33,050,319 | 27.05% | 0.08% |
| June 11, 2025 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 39,003,169 | 9999.99% | 0.05% |
| June 13, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 33,050,319 | 9999.99% | 0.05% |
| June 3, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | M | Common Stock | 11918 | $6.06 | 104,330.0000 | 33,050,319 | 12.90% | 0.04% |
| June 3, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | M | Stock Option (Right to Buy) | 11918 | $0.00 | 0.0000 | 33,050,319 | 100.00% | 0.04% |
| May 14, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 25000 | $14.59 | 92,412.0000 | 33,050,319 | 37.09% | 0.08% |
| May 8, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 2276 | $14.04 | 65,212.0000 | 33,050,319 | 3.62% | 0.01% |
| May 9, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 2200 | $14.25 | 67,412.0000 | 33,050,319 | 3.37% | 0.01% |
| April 8, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 2600 | $13.57 | 62,936.0000 | 33,050,319 | 4.31% | 0.01% |
| March 28, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 1512 | $13.75 | 60,336.0000 | 33,050,319 | 2.57% | 0.00% |
| March 26, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 2750 | $13.64 | 58,824.0000 | 33,050,319 | 4.90% | 0.01% |
| March 25, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 3180 | $13.36 | 56,074.0000 | 33,050,319 | 6.01% | 0.01% |
| March 22, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 3118 | $13.76 | 52,894.0000 | 33,050,319 | 6.26% | 0.01% |
| March 19, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 900 | $12.66 | 47,944.0000 | 33,050,319 | 1.91% | 0.00% |
| March 20, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 1128 | $12.66 | 49,072.0000 | 33,050,319 | 2.35% | 0.00% |
| March 21, 2024 | Entrada Therapeutics, Inc. | $TRDA | KIM PETER S | Director | P | Common Stock | 704 | $13.24 | 49,776.0000 | 33,050,319 | 1.43% | 0.00% |